| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0005 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |